A tale of two cannabinoids: the therapeutic rationale for combining tetrahydrocannabinol and cannabidiol. | Med Hypotheses;66(2): 234-46, 2006. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL TCIM Americas

Traditional, Complementary and Integrative Medicine in the Americas VHL

Subject descriptor lookup Advanced Search

A tale of two cannabinoids: the therapeutic rationale for combining tetrahydrocannabinol and cannabidiol.

Russo, Ethan; Guy, Geoffrey W.

Affiliation

Russo E; GW Pharmaceuticals, Porton Down Science Park, Salisbury, Wiltshire SP4 0JQ, UK. erusso@gwpharm.com

Med Hypotheses ; 66(2): 234-46, 2006.

Article in En | MEDLINE | ID: mdl-16209908

Subject(s)

Cannabidiol/administration & dosage; Dronabinol/administration & dosage; Animals; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Neoplasms/drug therapy

Search on Google

Database: MEDLINE Therapeutic Methods and Therapies TCIM: Plantas_medicinales Main subject: Dronabinol / Cannabidiol Language: En Journal: Med Hypotheses Year: 2006 Type: Article Affiliation country: United kingdom

Search on Google

Database: MEDLINE Therapeutic Methods and Therapies TCIM: Plantas_medicinales Main subject: Dronabinol / Cannabidiol Language: En Journal: Med Hypotheses Year: 2006 Type: Article Affiliation country: United kingdom